SCHEMBL20355351

SCHEMBL20355351

C=Nc1cc(F)c(F)cc1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12964083 0.75 LMNA (0.40) —
SCHEMBL22219455 0.71 SIGMAR1 (0.33) —
SCHEMBL30867032 0.71 ACHE (0.42) —
SCHEMBL5616902 0.71 ACHE (0.42) —
SCHEMBL15589318 0.70 ALDH1A1 (0.38) —
SCHEMBL24359602 0.69 DHFR (0.35) —
SCHEMBL21415482 0.69 HDAC1 (0.31) —
SCHEMBL24455151 0.69 — —
SCHEMBL16104754 0.69 — —
SCHEMBL10061283 0.68 CYP3A4 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018125800-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 — — WO disclosed
Send feedback